Profound Medical Corp. financial data

Symbol
PROF on Nasdaq
Location
Mississauga, Ontario, Canada
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 797% %
Quick Ratio 106% %
Debt-to-equity 22% %
Return On Equity -86% %
Return On Assets -71% %
Operating Margin -295% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30,193,592 shares
Common Stock, Shares, Outstanding 30,193,592 shares
Common Stock, Value, Issued $282,751,000 USD
Weighted Average Number of Shares Outstanding, Basic 30,104,497 shares 23%
Weighted Average Number of Shares Outstanding, Diluted 30,104,497 shares 23%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $14,297,000 USD 87%
Revenue from Contract with Customer, Excluding Assessed Tax $13,407,000 USD 99%
Cost of Revenue $3,933,000 USD 30%
Research and Development Expense $20,973,000 USD 30%
Operating Income (Loss) $42,230,000 USD 0.94%
Nonoperating Income (Expense) $2,875,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $39,355,000 USD 14%
Income Tax Expense (Benefit) $12,000 USD -32%
Net Income (Loss) Attributable to Parent $39,343,000 USD 15%
Earnings Per Share, Basic 1 USD/shares -32%
Earnings Per Share, Diluted 1 USD/shares -32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $24,826,000 USD
Inventory, Net $8,337,000 USD
Assets, Current $41,524,000 USD
Deferred Income Tax Assets, Net $80,000 USD
Property, Plant and Equipment, Net $338,000 USD
Operating Lease, Right-of-Use Asset $240,000 USD
Assets $42,305,000 USD
Accounts Payable, Current $717,000 USD
Employee-related Liabilities, Current $2,250,000 USD
Liabilities, Current $9,938,000 USD
Contract with Customer, Liability, Noncurrent $148,000 USD
Other Liabilities, Noncurrent $76,000 USD
Liabilities $10,162,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,750,000 USD
Retained Earnings (Accumulated Deficit) $279,566,000 USD
Stockholders' Equity Attributable to Parent $32,143,000 USD 4.6%
Liabilities and Equity $42,305,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 30,193,592 shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24,826,000 USD -8.5%
Depreciation $471,000 USD -43%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $39,303,000 USD -0.05%
Property, Plant and Equipment, Gross $1,947,000 USD
Operating Lease, Liability, Current $277,000 USD
Deferred Income Tax Expense (Benefit) $21,000 USD
Current Income Tax Expense (Benefit) $127,000 USD -44%
Additional Paid in Capital $24,208,000 USD
Share-based Payment Arrangement, Expense $4,551,000 USD 176%